Pros | ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. | ||
Cons | ![]() 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 7/23 | - | ||
Category,Subcateogry | Equity,Global - Other | Equity,Global - Other | ||
Fund Age | 12 Years | 12 Years | ||
Fund Size | 3019 Cr | 52 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹1000 Lumpsum ₹5000 | ||
Expense Ratio | 1.19% | 1.78% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | S&P 500 TR USD | MSCI Brazil 10/40 GR LCL |
No of Holdings | 64 | - | ||
Top 5 Holdings | Huntington Ingalls Industries Inc (3.13%) West Pharmaceutical Services Inc (2.98%) Corteva Inc (2.94%) Zimmer Biomet Holdings Inc (2.73%) Brown-Forman Corp Registered Shs -B- Non Vtg (2.71%) | - | ||
No of Sectors | 9 | - | ||
Top 3 Sectors | Health (25.97%) Tech (21%) Industrial (14.36%) | - | ||
Equity % | 98.41% | - | ||
Debt % | - | - | ||
P/E | 23.71 | 10.07 | ||
P/B | 3.23 | 1.48 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 12.81% | 13.72% | ||
3-Month Return | -6.74% | 6.63% | ||
6-Month Return | -8.06% | 7.88% | ||
1-Year Return | 1.26% | -2.78% | ||
3-Year Return | 12.56% | 4.68% | ||
5-Year Return | 14.35% | 8.32% |
Sharpe | 0.36 | -0.06 | ||
Alpha | -3.65 | - | ||
Beta | 1.05 | - | ||
Standard Deviation | 18.21 | 25.61 | ||
Information Ratio | -0.52 | - |
Description | ICICI Prudential US Bluechip Equity Fund Direct Plan Growth is an equity fund.The fund could potentially beat inflation in the long-run. | HSBC Brazil Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Ritesh Lunawat | Sonal Gupta |